Tamtam Try Tamtam free
Charité - Universitätsmedizin Berlin logo

Charité - Universitätsmedizin Berlin account plan

Top hospital in Berlin

At a glance

Charité is Germany's largest university medical centre: 4 Berlin campuses, 3,293 beds, 25,256 staff and EUR 2,191.3 million revenue in 2025.

Charité – Universitätsmedizin Berlin is Germany's largest university medical centre, combining a maximum-care hospital, the medical faculty for research and teaching, and a translational research area (the Berlin Institute of Health in the Charité), with more than 100 clinics and institutes on 4 campuses. Patient care is paid by health insurers, while research, teaching and most investment are funded by the Land Berlin. In 2025 revenue was EUR 2,191.3 million (2024: EUR 2,046.3 million) and total income about EUR 3.1 billion including third-party funds and investment grants; the net loss narrowed to EUR 63.6 million from EUR 87.4 million. It employed 25,256 people group-wide on average in 2025 and treated 147,997 inpatient and day cases and 853,377 outpatient cases.

Business units

Strategic priorities

Financial consolidation
The Charité is on a consolidation course, raising clinical output while cutting costs; the 2025 loss of EUR 63.6 million beat the business plan, but the board says it will not reach a balanced result in the following financial year either.
Epic hospital information system
Epic Systems is to be rolled out across the whole hospital by the end of 2029, a project with a planned volume of EUR 200 million financed with the Charité's own borrowing.
Artificial intelligence in care
AI activities were brought together in a new Institute for Artificial Intelligence in Medicine, meant to bring AI solutions reliably into care and prove their benefit with evidence; the CEO expects agentic AI to take over part of today's human tasks.
Cell and gene therapy
The CEO names cell and gene therapy as the area of most importance for the Charité's innovation work, backed by the Berlin Center for Gene and Cell Therapies driven with Bayer AG.
Prevention
Prevention is the second innovation focus, through interaction with academic and industrial partners and centres such as the Friede Springer – Cardiovascular Prevention Center.
Medical data
A joint venture with Schwarz Digits is to link medical data securely as a basis for prevention, research and treatment options.

Investments and deals

2025 capital spending
EUR 132 million was invested in property, plant and equipment, intangible and financial assets in 2025, mostly financed by the Land Berlin.
New DHZC heart centre building
The new Deutsches Herzzentrum der Charité building on Campus Virchow-Klinikum received EUR 39.1 million in 2025; its symbolic foundation stone was laid that year.
Epic Systems roll-out
A planned EUR 200 million hospital information system project, due across the hospital by the end of 2029; the Charité is the first German user.
Berlin Center for Gene and Cell Therapies
Groundbreaking took place for the centre driven with Bayer AG; research buildings Der simulierte Mensch and Berlin Center for Advanced Therapies received EUR 10.3 million in 2025.

Challenges and risks

Continuing losses and negative equity
The Charité lost EUR 63.6 million in 2025 and its deficit not covered by equity rose to EUR 237.4 million; personnel expenses rose EUR 106.7 million to EUR 1,660.6 million.
Workforce demographics and labour talks
The CEO expects about a third of the workforce to be lost over the next ten years as baby boomers retire; Verdi's relief-agreement demands would mean up to 300 additional nurses and more than EUR 20 million of extra costs.
Cybersecurity
A recent cyberattack took almost 140,000 contact records, and the CEO called for massive efforts to improve cybersecurity.
Low digitalisation
The CEO calls the Charité's degree of digitalisation in need of improvement, and the Epic award drew criticism over its cost, US base and closed system.
Health security preparedness
The CEO says Germany is still poorly prepared for health security threats and expects the forthcoming Health Security Act to be highly complex.

What leadership says

“We are convinced that the future health system in Germany will rely much on preventive measures”

Prof. Dr. Heyo K. Kroemer, Chief Executive Officer · bio:cap interview, 15 April 2026

“We try to reorganise the entire business of innovation, just taking out the hurdles”

Prof. Dr. Heyo K. Kroemer, Chief Executive Officer · bio:cap interview, 15 April 2026

“Es müsste massive Anstrengungen geben, um die Cybersicherheit zu verbessern”

Prof. Dr. Heyo K. Kroemer, Chief Executive Officer · Press briefing reported by Deutsches Ärzteblatt, 12 November 2026

Where a supplier can help

Epic implementation support
The EUR 200 million Epic roll-out due by the end of 2029 needs integration, data migration, training and clinical workflow support across all departments.
Cybersecurity hardening
After the cyberattack on contact records and the CEO's call for massive efforts, security monitoring, data protection and incident response suppliers have a direct opening.
Efficiency under consolidation
The consolidation course and rising personnel costs favour suppliers that cut material, maintenance or administrative costs or raise clinical throughput.
Clinical AI and workforce relief
The new AI institute and the expected loss of a third of the workforce point to demand for evidence-backed AI tools that take over routine tasks.
Industry partnerships in cell and gene therapy
The Charité is building new interfaces with industrial partners in cell and gene therapy and prevention, an entry point for life-science and biotech companies.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Charité - Universitätsmedizin Berlin?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Charité - Universitätsmedizin Berlin

What is Charité - Universitätsmedizin Berlin?

It is Germany's largest university medical centre, combining a maximum-care hospital, a medical faculty and the Berlin Institute of Health in the Charité, with more than 100 clinics and institutes on 4 campuses.

What was the Charité's revenue in 2025?

Revenue was EUR 2,191.3 million in 2025, with total income of about EUR 3.1 billion including third-party funds and investment grants. The year closed with a net loss of EUR 63.6 million.

How many people work at the Charité?

On average 25,256 people worked across the group in 2025, 21,493 of them at the Charité itself.

Who leads the Charité?

CEO Prof. Dr. Heyo K. Kroemer chairs the board, with Astrid Lurati (Finance and Infrastructure), Carla Eysel (Personnel and Nursing), Prof. Dr. Martin E. Kreis (Clinical Care), Dean Prof. Dr. Joachim Spranger and Prof. Dr. Christopher Baum.

What are the Charité's priorities?

Financial consolidation, the Epic hospital information system, AI in care, cell and gene therapy, and prevention.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)